{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:03:53Z","timestamp":1756994633113},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[1981,3,1]],"date-time":"1981-03-01T00:00:00Z","timestamp":352252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1981,3]]},"DOI":"10.1007\/bf01664005","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T19:35:01Z","timestamp":1115580901000},"page":"61-82","source":"Crossref","is-referenced-by-count":13,"title":["The endocrine profile of bromocriptine: Its application in endocrine diseases"],"prefix":"10.1007","volume":"51","author":[{"given":"Ioana","family":"Lancranjan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2265.1977.tb03351.x","volume":"7","author":"B. Ambrosi","year":"1977","unstructured":"Ambrosi, B., Bara, R., Trawaglini, P., Weber, G., Beck Peccoz, P., Rondena, M., Elli, R., Faglia, C.: Study of the effects of bromocriptine on sexual impotence. Clin. Endocrinol.7, 417\u2013421 (1977).","journal-title":"Clin. Endocrinol."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJM197906143002411","volume":"300","author":"S. L. Aronoff","year":"1979","unstructured":"Aronoff, S. L., Daughaday, W. H., Laws, E. R.: Bromocriptine treatment of prolactinomas. N. Engl. J. Med.300, 1391 (1979).","journal-title":"N. Engl. J. Med."},{"key":"CR3","first-page":"14","volume":"13","author":"M. C. Bazan","year":"1980","unstructured":"Bazan, M. C.: Effects of bromoergocriptine on growth hormone secretion in normal children. Pediatr. Res.13, 14 (1980).","journal-title":"Pediatr. Res."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1210\/jcem-47-4-807","volume":"47","author":"R. D. Bell","year":"1978","unstructured":"Bell, R. D., Carruth, A., Rosenberg, R. N., Boyar, R. M.: Effect of dopamine agonist (lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. J. Clin. Endocrinol. Metab.47, 807\u2013811 (1978).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2265.1976.tb02831.x","volume":"5","author":"G. Benker","year":"1976","unstructured":"Benker, G., Hackenberg, K., Hamburger, B., Reinwein, D.: Effects of growth hormone release-inhibiting hormone and bromocriptine (CB-154) in states of abnormal pituitary-adrenal function. Clin. Endocrinol.5, 187\u2013190 (1976).","journal-title":"Clin. Endocrinol."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.3.5828.669","volume":"3","author":"G. M. Besser","year":"1972","unstructured":"Besser, G. M., Parke, L., Edwards, C. R. W., Forsyth, I. A., McNeilly, A. S.: Galactorrhea: Successful treatment with reduction of plasma prolactin levels by brom-ergocriptine. Br. Med. J.3, 669\u2013672 (1972).","journal-title":"Br. Med. J."},{"issue":"Suppl. 1","key":"CR7","first-page":"64","volume":"52","author":"G. M. Besser","year":"1976","unstructured":"Besser, G. M., Thorner, M. O.: Bromocriptine in the treatment of the hyperprolactinaemia-hypogonadism syndromes. Postgrad. Med. J.52, Suppl. 1, 64\u201370 (1976).","journal-title":"Postgrad. Med. J."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1210\/jcem-48-1-9","volume":"48","author":"M. Bigazzi","year":"1979","unstructured":"Bigazzi, M., Ronga, R., Lancranjan, I., Ferraro, S., Branconi, F., Buzzoni, P., Martorana, G., Scarselli, G. F., del Pozo, E.: A pregnancy in an acromegalic woman during bromocriptine treatment: Effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J. Clin. Endocrinol. Metab.48, 9\u201312 (1979).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1210\/jcem-42-1-132","volume":"42","author":"H. G. Bohnet","year":"1976","unstructured":"Bohnet, H. G., Dahlen, H. G., Wuttke, W., Schneider, H. P. G.: Hyperprolactinaemic anovulatory syndrome. J. Clin. Endocrinol. Metab.42, 132\u2013143 (1976).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR10","doi-asserted-by":"crossref","unstructured":"Bommer, J., del Pozo, E., Ritz, E., Bommer, G.: Improved sexual function in male haemodialysis patients on bromocriptine. Lancet1979, 496\u2013497.","DOI":"10.1016\/S0140-6736(79)91553-8"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1051\/rnd:19770409","volume":"17","author":"D. Boucher","year":"1977","unstructured":"Boucher, D., Hermabessiere, J., Doly, M.: Prolactin secretion in infertile men before and after treatment with bromocriptine. Ann. Biol. anim. Bioch. Biophys.17, 483\u2013498 (1977).","journal-title":"Ann. Biol. anim. Bioch. Biophys."},{"key":"CR12","first-page":"884","volume":"41","author":"R. Brun del Re.","year":"1973","unstructured":"Brun, del Re., R., del Pozo, E., de Grandi, P., Friesen, H., Hinselmann, M., Wyss, H.: Prolactin inhibition and suppression of puerperal lactation by a Br-ergocryptine (CB 154). A comparison with estrogen. Obstet. Gynecol.41, 884\u2013890 (1973).","journal-title":"Obstet. Gynecol."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0024-3205(78)90616-1","volume":"22","author":"E. Caine","year":"1978","unstructured":"Caine, E., Kartzinel, R., Ebert, M., Carter, A. C.: Neuroendocrine function in Huntington's disease: Dopaminergic regulation of prolactin release. Life Sci.22, 911\u2013918 (1978).","journal-title":"Life Sci."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1210\/jcem-44-5-870","volume":"44","author":"T. Caraceni","year":"1977","unstructured":"Caraceni, T., Panerai, A. E., Parati, E. A., Cocchi, D., M\u00fcller, E. E.: Altered growth hormone and prolactin response to dopaminergic stimulation in Huntington's chorea. J. Clin. Endocrinol. Metab.44, 870\u2013875 (1977).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1172\/JCI109356","volume":"63","author":"R. M. Carey","year":"1979","unstructured":"Carey, R. M., Thorner, M. O., Ortt, E. M.: Effect of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. J. Clin. Invest.63, 727\u2013735 (1979).","journal-title":"J. Clin. Invest."},{"key":"CR16","volume-title":"Proceedings of the symposium on endocrine causes of menstrual disorders, Memphis","author":"J. Carter","year":"1977","unstructured":"Carter, J., Gomez, F., Friesen, H. G.: Human prolactin and galactorrhea amenorrhea syndromes. In: Proceedings of the symposium on endocrine causes of menstrual disorders, Memphis, March 1977. Chicago: Medical Year Book Publishers."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp.41.2.135","volume":"41","author":"R. J. Chalmers","year":"1978","unstructured":"Chalmers, R. J., Johnson, R. H., Keogh, H. J., Nanda, R. N.: Growth hormone and prolactin responded bromocriptine in patients with Huntington's chorea. J. Neurol. Neurosurg. Psychiatr.41, 135\u2013139 (1978).","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(78)92671-5","volume":"2","author":"B. Corenblum","year":"1978","unstructured":"Corenblum, B.: Bromocriptine in pituitary tumors. Lancet2, 786 (1978).","journal-title":"Lancet"},{"key":"CR19","first-page":"614A","volume":"23","author":"B. Corenblum","year":"1975","unstructured":"Corenblum, B., Webster, B. R., Mortimer, C. B., Ezrin, C.: Possible antitumor effect of 2-bromoergocryptine (CB-154, Sandoz) in two patients with large prolactin secreting pituitary adenomas. Clin. Res.23, 614A (1975).","journal-title":"Clin. Res."},{"key":"CR20","first-page":"110","volume":"Suppl. 184","author":"P. Delvoye","year":"1977","unstructured":"Delvoye, P., Taubert, H. D., J\u00fcrgensen, O., L'Hermite, M., Delongne, J., Robyn, C.: Influence of circulating prolactin increased by a psychotropic drug on gonadotropin and progesterone secretion. Acta Endocrin. (Kbh.), Suppl.184, 110 (1977).","journal-title":"Acta Endocrin. (Kbh.)"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1677\/joe.0.0610411","volume":"61","author":"C. Davies","year":"1974","unstructured":"Davies, C., Jacobi, J., Lloyd, H. M., Meares, J. D.: DNA synthesis and secretion of prolactin and growth hormone by the pituitary gland of the male rat: Effects of diethyl stilboestrol and 2-brom-\u03b1-ergokryptinemethansulphanate. J. Endocrinol.61, 411\u2013417 (1974).","journal-title":"J. Endocrinol."},{"key":"CR22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(75)92132-7","volume":"2","author":"C. R. W. Edwards","year":"1975","unstructured":"Edwards, C. R. W., Thorner, M. O., Miall, P. A., Al-Dujaili, E. A. S., Hanker, J. P., Besser, G. M.: Inhibition of plasma aldosterone response to frusemide by bromocriptine. Lancet2, 903\u2013905 (1975).","journal-title":"Lancet"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jcem-50-1-103","volume":"50","author":"W. S. Evans","year":"1980","unstructured":"Evans, W. S., Rogol, A. D., Mac Leod, R. M., Thorner, M. O.: Dopaminergic mechanisms and LH secretion: I. Acute administration of the dopamine agonist bromocriptine does not inhibit LH release in hyperprolactinemic women. J. Clin. Endocrinol. Metab.50, 103\u2013107 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR24","unstructured":"Faglia, G., Fonzo, D., Ambrosi, B., Gaggini, M., Gallone, G., Moriondo, P., Travaglini, P., Elli, R.: Prolactin and hypothalamic-pituitary-testicular function in men. Lecture at the VIth Int. Congress of Endocrinology, Melbourne, 1980."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0028-1093551","volume":"9","author":"V. Felt","year":"1977","unstructured":"Felt, V., Nedividkova, J.: Effect of bromocriptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and tridothyroxine (T3) in hypothyroidism. Horm. Metab. Res.9, 274\u2013277 (1977).","journal-title":"Horm. Metab. Res."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/BF02147804","volume":"24","author":"E. Fl\u00fcckiger","year":"1968","unstructured":"Fl\u00fcckiger, E., Wagner, H. R.: 2 Br-\u03b1-Ergokryptin: Beeinflussung von Fertilit\u00e4t und Lactation bei der Ratte. Experientia24, 1130 (1968).","journal-title":"Experientia"},{"key":"CR27","unstructured":"Fl\u00fcckiger, E., Vigouret, J. M., Wagner, H. R.: Ergot compounds and prolactin secretion. In: Progress in Prolactin Physiology and Pathology (Robyn, C., Harter, M., eds.), Vol. 2, pp. 383\u2013396. Elsevier\/North-Holland Biochemical Press. 1978."},{"key":"CR28","first-page":"123","volume-title":"The Hypothalamus","author":"K. Fuxe","year":"1970","unstructured":"Fuxe, K., H\u00f6kfelt, T.: Central monoaminergic systems and hypothalamic function. In: The Hypothalamus (Martini, L., Motta, M., Fraschini, F., eds.), pp. 123\u2013138. New York: Academic Press. 1970."},{"key":"CR29","first-page":"41","volume-title":"Clinical Reproductive Neuroendocrinology","author":"K. Fuxe","year":"1977","unstructured":"Fuxe, K., H\u00f6kfelt, T., Johanson, O., Eneroth, P., Gustafson, J. A., Skett, P., Jeffcoat, S., Fraser, H.: Functional morphology of the median eminence. In: Clinical Reproductive Neuroendocrinology (Hubinot, L'Hermite, Robyn eds.), pp. 41\u201353. Basel: Karger. 1977."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.170.3959.745","volume":"170","author":"A. G. Frantz","year":"1970","unstructured":"Frantz, A. G., Kleinberg, D. L.: Prolactin: Evidence that it is separate from growth hormone in human blood. Science170, 745\u2013749 (1970).","journal-title":"Science"},{"key":"CR31","first-page":"147","volume-title":"Ergot Compounds and Brain Function","author":"H. G. Friesen","year":"1980","unstructured":"Friesen, H. G.: Bromocriptine therapy of hyperprolactinemic disorders. In: Ergot Compounds and Brain Function (Goldstein, M., Calne, D. B., Lieberman, A., Thorner, M. O., eds.), pp. 147\u2013154. New York: Raven Press. 1980."},{"key":"CR32","first-page":"423","volume":"2","author":"M. R. Hayden","year":"1976","unstructured":"Hayden, M. R., Paul, M., Vinik, A. I., Beighton, P.: Impaired prolactin release in Huntington's chorea. Lancet2, 423\u2013426 (1976).","journal-title":"Lancet"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.68.8.1902","volume":"68","author":"P. Hwang","year":"1971","unstructured":"Hwang, P., Guyda, H., Friesen, H. G.: A radioimmunoassay for human prolactin. Proc. National Acad. Sci. U.S.A.68, 1902\u20131906 (1971).","journal-title":"Proc. National Acad. Sci. U.S.A."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0021-9258(19)45475-6","volume":"247","author":"P. Hwang","year":"1972","unstructured":"Hwang, P., Guyda, H., Friesen, H. G.: Purification of human prolactin. J. Biol. Chem.247, 1955\u20131958 (1972).","journal-title":"J. Biol. Chem."},{"key":"CR35","first-page":"189","volume-title":"Recent Advances in the Diagnosis and Treatment of Pituitary Tumors","author":"H. Imura","year":"1979","unstructured":"Imura, H., Kato, Y., Oseko, F., Asoo, T., Motohashi, T.: Hyperprolactinemia. In: Recent Advances in the Diagnosis and Treatment of Pituitary Tumors (Linfoot, J. A., ed.), pp. 189\u2013205. New York: Raven Press. 1979."},{"key":"CR36","first-page":"1084","volume":"1","author":"A. L. Kennedy","year":"1977","unstructured":"Kennedy, A. L., Montgomery, D. A. D.: Bromocriptine for Cushing's disease. Br. Med. J.1, 1084\u20131085 (1977).","journal-title":"Br. Med. J."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jcem-39-2-391","volume":"39","author":"M. Kiyoshi","year":"1974","unstructured":"Kiyoshi, M., Toshio, O., Mitsuko, H., Kaichiro, I., Yuichi, K.: Inhibition of thyrotropin and prolactin secretions in primary hypothyroidism by 2-Br-alpha-ergocryptine. J. Clin. Endocrinol. Metab.39, 391\u2013394 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1210\/jcem-45-4-825","volume":"45","author":"M. P. K\u00f6nig","year":"1977","unstructured":"K\u00f6nig, M. P., Zuppinger, K., Liechti, B.: Hyperprolactinemia as a cause of delayed puberty: successful treatment with bromocriptine. J. Clin. Endocr.45, 825\u2013828 (1977).","journal-title":"J. Clin. Endocr."},{"key":"CR39","first-page":"236","volume":"33","author":"H. I. Kort","year":"1980","unstructured":"Kort, H. I.: Ovarian function and morphology following treatment with bromocriptine. Fertil. steril.33, 236\u2013240 (1980).","journal-title":"Fertil. steril."},{"key":"CR40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/jcem-44-4-728","volume":"44","author":"G. C. L. Lachelin","year":"1977","unstructured":"Lachelin, G. C. L., Leblanc, H., Yen, S. S. C.: The inhibitory effect of dopamine agonists on LH release in women. J. Clin. Endocrinol. Metab.44, 728\u2013732 (1977).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR41","unstructured":"Laihinen, A., Irjala, K., Rinne, U. K.: Bromocriptine suppression test for measuring brain dopamine receptor function in Parkinsonian patients. Abstr. Proc. 23rd Scandinavian Neurology Congress, Reykjavik, 1980."},{"key":"CR42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(76)90656-5","volume":"2","author":"S. W. J. Lamberts","year":"1976","unstructured":"Lamberts, S. W. J., Birkenbaeger, J. C.: Bromocriptine in Nelson's syndrome and Cushing's disease. Lancet2, 811 (1976).","journal-title":"Lancet"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2265.1977.tb01314.x","volume":"7","author":"S. W. J. Lamberts","year":"1977","unstructured":"Lamberts, S. W. J., Timmermans, H. A. T., de Jong, F. H., Birkenhaeger, J. C.: The role of dopaminergic depletion in the pathogenesis of Cushing's disease and the possible consequences for medical therapy. Clin. Endocrinol.7, 185\u2013193 (1977).","journal-title":"Clin. Endocrinol."},{"key":"CR44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/joe.0.0700315","volume":"70","author":"S. W. J. Lamberts","year":"1976","unstructured":"Lamberts, S. W. J., Birkenhaeger, J. C.: Effect of bromocriptine in pituitarydependent Cushing's syndrome. J. Endocrinol.70, 315\u2013316 (1976).","journal-title":"J. Endocrinol."},{"key":"CR45","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1210\/jcem-51-2-307","volume":"51","author":"S. W. J. Lamberts","year":"1980","unstructured":"Lamberts, S. W. J., Klijn, J. G. M., de Quijada, M., Timmermans, H. A. T., Uitterlingen, P., de Jong, F. H., Birkenhaeger, J. C.: The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome. J. Clin. Endocrinol. Metab.51, 307\u2013311 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR46","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0140-6736(79)92976-3","volume":"1","author":"A. M. Landolt","year":"1979","unstructured":"Landolt, A. M., W\u00fcthrich, R., Fellmann, H.: Regression of pituitary prolactinoma after treatment. Lancet1, 1082\u20131083 (1979).","journal-title":"Lancet"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1210\/jcem-47-3-480","volume":"47","author":"W. Leebaw","year":"1978","unstructured":"Leebaw, W., Lee, A. L., Woolf, P. D.: Dopamine affects basal and augmented pituitary hormone secretion. J. Clin. Endocrinol. Metab.47, 480\u2013487 (1978).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR48","first-page":"179","volume-title":"Prolactin and Human Reproduction","author":"M. L'Hermite","year":"1977","unstructured":"L'Hermite, M., Coufriez, A., Robyn, C.: Pathophysiology of human prolactin secretion with special reference to prolactin-secreting pituitary adenomas and isolated galactorrhoea. In: Prolactin and Human Reproduction (Crosigniani, P. G., Robyn, C., eds.), pp. 179\u2013202. London-New York-San Francisco: Academic Press. 1977."},{"key":"CR49","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1210\/jcem-38-5-910","volume":"38","author":"A. Liuzzi","year":"1974","unstructured":"Liuzzi, A., Chiodini, P. G., Botalla, L., Cremascoli, G., M\u00fcller, E. E., Silvestrini, F.: Decreased plasma growth hormone (GH) levels in acromegalics following CB 154 (2-Br-\u03b1-ergocryptine) administration. J. Clin. Endocrinol. Metab.38, 910\u2013912 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR50","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/jcem-35-6-941","volume":"35","author":"A. Liuzzi","year":"1972","unstructured":"Liuzzi, A., Chiodini, P. G., Botalla, L., Cremascoli, G., Silvestrini, F.: Inhibitory effect of L-dopa on GH release in acromegalic patients. J. Clin. Endocrinol. Metab.35, 941\u2013943 (1972).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jcem-39-5-871","volume":"39","author":"A. Liuzzi","year":"1974","unstructured":"Liuzzi, A., Chiodini, P. G., Botalla, L., Silvestrini, F., M\u00fcller, E. E.: Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: Homogeneity in the two responses. J. Clin. Endocrinol. Metab.39, 871\u2013876 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/255497a0","volume":"255","author":"H. M. Lloyd","year":"1975","unstructured":"Lloyd, H. M., Meares, J. D., Jacobi, J.: Effects of estrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature255, 497\u2013498 (1975).","journal-title":"Nature"},{"key":"CR53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1210\/jcem-39-2-229","volume":"39","author":"W. B. Malarkey","year":"1974","unstructured":"Malarkey, W. B., Cyrus, J., Paulson, G. W.: Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-DOPA therapy. J. Clin. Endocrinol. Metab.39, 229\u2013235 (1974).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR54","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1056\/NEJM197902083000606","volume":"300","author":"A. M. McGregor","year":"1979","unstructured":"McGregor, A. M., Scanlon, M. F., Hall, K., Cook, D. B., Hall, R.: Reduction in size of a pituitary tumor by bromocriptine therapy. N. Engl. J. Med.300, 291\u2013293 (1979).","journal-title":"N. Engl. J. Med."},{"key":"CR55","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/bmj.2.6192.700","volume":"2","author":"A. M. McGregor","year":"1979","unstructured":"McGregor, A. M., Scanlon, M. F., Hall, R., Hall, K.: Effects of bromocriptine on pituitary tumour size. Br. Med. J.2, 700\u2013703 (1979).","journal-title":"Br. Med. J."},{"key":"CR56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/250653a0","volume":"250","author":"K. P. McNatty","year":"1974","unstructured":"McNatty, K. P., Sawers, R. S., McNeilly, A. S.: A possible role for prolactin in control of steroid secretion by the human Graafian follicle. Nature250, 653\u2013655 (1974).","journal-title":"Nature"},{"key":"CR57","first-page":"303","volume":"12","author":"J. V. Milligan","year":"1969","unstructured":"Milligan, J. V., Kraicer, J.: Calcium-45 uptake and potassium-induced release of ACTH from the adenohypophyses. Physiologist (Wash.)12, 303 (1969).","journal-title":"Physiologist (Wash.)"},{"key":"CR58","first-page":"319 to 334","volume-title":"Advances in Neurology, Vol. 23","author":"E. E. M\u00fcller","year":"1979","unstructured":"M\u00fcller, E. E., Parati, E. A., Cocchi, D., Zanardi, P., Coraceni, T.: Dopaminergic drugs on growth hormone and prolactin secretion in Huntington's disease. In: Advances in Neurology, Vol. 23 (Chase et al., ed.), pp. 319 to 334. New York: Raven Press. 1979."},{"issue":"Suppl. 1","key":"CR59","first-page":"63","volume":"16","author":"E. E. M\u00fcller","year":"1978","unstructured":"M\u00fcller, E. E., Cocchi, D., Panerai, A. E., Gil-Ad, I., Locatelli, C., Mantegazza, P.: Pituitary hormones and ergot alkaloids. Pharmacology16, Suppl. 1, 63\u201377 (1978).","journal-title":"Pharmacology"},{"key":"CR60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02119225","volume":"226","author":"D. M\u00fchlenstedt","year":"1978","unstructured":"M\u00fchlenstedt, D., Osmers, F., Schneider, H. P. G.: Regression eines Hypophysenadenoms unter Bromocriptin. Arch. Gynecol.226, 341\u2013346 (1978).","journal-title":"Arch. Gynecol."},{"key":"CR61","first-page":"313","volume-title":"Human Prolactin","author":"H. Nagasawa","year":"1973","unstructured":"Nagasawa, H., Yanai, R., Fl\u00fcckiger, E.: Conteraction by 2-Br-alphaergocryptine of pituitary prolactin release promoted by dibutyriladenosine-3\u2032, 5\u2032-monophosphate: In: Human Prolactin (Pastells, J. L., Robyn, C., eds.), pp. 313\u2013315. Amsterdam: Excerpta Medica. 1973."},{"key":"CR62","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0015-0282(16)43702-7","volume":"30","author":"S. J. Nillius","year":"1978","unstructured":"Nillius, S. J., Berg, T., Lundberg, P. O., et al.: Regression of a prolactinsecreting pituitary tumor during long-term treatment with bromocriptine. Fertil. Steril.30, 710\u2013712 (1978).","journal-title":"Fertil. Steril."},{"key":"CR63","unstructured":"Nillius, S. J.: Bromocriptine therapy of prolactin-secreting pituitary tumors, Abst., p. 122. In: Proceedings of the 23rd Scandinavian Neurology Congress, Reykjavik, 1980."},{"key":"CR64","first-page":"188","volume":"32","author":"J. L. Pastells","year":"1971","unstructured":"Pastells, J. L., Danguy, A., Frerotte, M., Ectors, F.: Inhibition de la s\u00e9cr\u00e9tion de prolactine par l'ergocornine et la 2-Br-\u03b1-ergocryptine: action directe sur l'hypophyse en culture. Ann. Endocr. (Paris)32, 188\u2013192 (1971).","journal-title":"Ann. Endocr. (Paris)"},{"key":"CR65","unstructured":"Parkes, J. D., Prince, P. A., Marsden, C. D.: Movement, growth hormone and prolactin responses to dopamine and dopamine agonists in neurotransmitter systems and their clinical disorders, Legg. N.Y., pp. 115 to 127, 1979."},{"key":"CR66","first-page":"847","volume":"103","author":"E. Pozo del","year":"1973","unstructured":"del Pozo, E., Friesen, H. G., Burmeister, P.: Endocrine profile of a specific prolactin inhibitor: Br-ergocryptine (CB 154). A preliminary report. Schweiz. Med. Wschr.103, 847\u2013848 (1973).","journal-title":"Schweiz. Med. Wschr."},{"key":"CR67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000178703","volume":"7","author":"E. Pozo del","year":"1976","unstructured":"del Pozo, E., Ohnhaus, E. E.: Lack of effect of acute prolactin suppression on renal water, sodium and potassium excretion during sleep. Horm. Res.7, 11\u201315 (1976).","journal-title":"Horm. Res."},{"issue":"Suppl.","key":"CR68","first-page":"47","volume":"6","author":"E. Pozo del","year":"1977","unstructured":"del Pozo, E., Darragh, A., Lancranjan, I., Ebeling, D., Burmeister, P., B\u00fchler, F., Marbach, P., Braun, P.: Effect of bromocriptine on the endocrine system and fetal development. Clinical Endocrinology6, Suppl., 47\u201355 (1977).","journal-title":"Clinical Endocrinology"},{"key":"CR69","first-page":"207","volume-title":"Frontiers in Neuroendocrinology, Vol. 5","author":"E. Pozo del","year":"1978","unstructured":"del Pozo, E., Lancranjan, I.: Clinical use of drugs modifying the release of anterior pituitary hormones. In: Frontiers in Neuroendocrinology, Vol. 5 (Ganong, W. F., Martini, L., eds.), pp. 207\u2013247. New York: Raven Press. 1978."},{"key":"CR70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000178998","volume":"10","author":"E. Pozo del","year":"1979","unstructured":"del Pozo, E., Brownell, J.: Prolactin: 1. Mechanism of control, peripheral actions and modification by drugs. Hormone Research10, 143\u2013172 (1979).","journal-title":"Hormone Research"},{"key":"CR71","first-page":"71","volume-title":"Prolactin and Human Reproduction","author":"C. Robyn","year":"1977","unstructured":"Robyn, C., Delvoye, P., Van Exter, C., Vekemans, M., Caufriez, A., de Nayer, P., Delogne-Desnoeck, J., L'Hermite, M.: Physiological and pharmacological factors influencing prolactin secretion and their relation to human reproduction. In: Prolactin and Human Reproduction (Crosignani, P. G., Robyn, C., eds.), pp. 71\u201396. London-New York-San Francisco: Academic Press. 1977."},{"key":"CR72","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1471-0528.1973.tb02954.x","volume":"80","author":"R. Rolland","year":"1973","unstructured":"Rolland, R., Schellekens, L. A.: A new approach to the inhibition of puerperal lactation. J. Obstet. Gyneacol. Br. Commonwealth80, 945\u2013951 (1973).","journal-title":"J. Obstet. Gyneacol. Br. Commonwealth"},{"key":"CR73","unstructured":"Roulier, R., Mattei, A., Franchimont, P.: Prolactin in male reproductive functions. In: Progress in Prolactin Physiology and Pharmacology (Robyn, C., Horter, M., eds.), pp. 305\u2013316. Elsevier\/North-Holland Biomedical Press. 1978."},{"key":"CR74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00667138","volume":"221","author":"K. D. Schulz","year":"1976","unstructured":"Schulz, K. D., Geiger, W., del Pozo, E., Lose, K. H., K\u00fcnzig, H. J., Lancranjan, I.: The influence of the prolactin inhibitor bromocriptine (CB 154) on human luetal function in vivo. Arch. Gyn\u00e4kol.221, 93\u201396 (1976).","journal-title":"Arch. Gyn\u00e4kol."},{"key":"CR75","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0002-9378(78)90753-6","volume":"132","author":"K. D. Schulz","year":"1978","unstructured":"Schulz, K. D., Geiger, W., del Pozo, E., K\u00fcnzig, H. J.: Pattern of sexual steroids, prolactin, and gonatropic hormones under prolactin inhibition in normally cycling women. Am. J. Obstet. Gynaecol.132, 561\u2013566 (1978).","journal-title":"Am. J. Obstet. Gynaecol."},{"key":"CR76","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jcem-43-1-198","volume":"43","author":"M. Sepp\u00e4l\u00e4","year":"1976","unstructured":"Sepp\u00e4l\u00e4, M., Linn\u00e9rus, H. A., Hirvonen, E., Rauta, T.: Bromocriptine increases plasma estradiol 17B concentration in amenorrhea patients with normal serum prolactin. J. Clin. Endocrinol. Metab.43, 474\u2013476 (1976).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR77","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1152\/ajplegacy.1954.179.2.301","volume":"179","author":"M. C. Shelesnyak","year":"1954","unstructured":"Shelesnyak, M. C.: Ergotoxine inhibition of deciduoma formation, and its reversal by progesterone. Am. J. Physiol.179, 301\u2013304 (1954).","journal-title":"Am. J. Physiol."},{"key":"CR78","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/endo-55-1-85","volume":"55","author":"M. C. Shelesnyak","year":"1954","unstructured":"Shelesnyak, M. C.: The action of selected drugs on deciduoma formation. Endocrinology55, 85\u201389 (1954).","journal-title":"Endocrinology"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(78)91764-6","volume":"2","author":"L. G. Sobrinho","year":"1978","unstructured":"Sobrinho, L. G., Nunes, M. C. P., Santos, M. A., Manricio, J. C.: Radiological evidence for regression of prolactinoma after treatment with bromocriptine. Lancet2, 257\u2013258 (1978).","journal-title":"Lancet"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01675313","volume":"42","author":"H. Stepien","year":"1978","unstructured":"Stepien, H., Wolanink, A., Pawlikowski, M.: Effects of pimozide and bromocriptine on anterior pituitary cell proliferation. J. Neural Transm.42, 239\u2013244 (1978).","journal-title":"J. Neural Transm."},{"key":"CR81","first-page":"353","volume-title":"Molecular Genetics and Developmental Biology","author":"A. H. Tashjian","year":"1972","unstructured":"Tashjian, A. H., Hoyt, R. F.: Transient control of organ specific functions in pituitary cells in culture. In: Molecular Genetics and Developmental Biology (Sussman, M., ed.), pp. 353\u2013387. Englewood Cliffs, N. J.: Prentice-Hall. 1972."},{"key":"CR82","first-page":"285","volume-title":"Prolactin and Human Reproduction","author":"M. O. Thorner","year":"1977","unstructured":"Thorner, M. O., Besser, G. M.: Hyperprolactinaemia and gonadal function: Results of bromocriptine treatment. In: Prolactin and Human Reproduction (Crosignani, P. G., Robyn, C., eds.), pp. 285\u2013301. New York: Academic Press. 1977."},{"key":"CR83","first-page":"165","volume-title":"Ergot Compounds and Brain Function","author":"M. O. Thorner","year":"1980","unstructured":"Thorner, M. O., Evans, W. S., Mac Leod, R. M., Nunley, W. C., Rogol, A. D., Morris, J. L., Besser, G. M.: Hyperprolactinemia: Current concepts of management including medical therapy with bromocriptine. In: Ergot Compounds and Brain Function (Goldstein, M., Calne, D. B., Liberman, A., Thorner, M. O., eds.), pp. 165\u2013190. New York: Raven Press. 1980 a."},{"key":"CR84","unstructured":"Thorner, M.: The role of dopaminomimetics in the treatment of prolactin disorders. Lecture at the symposium: Clinical pharmacology of apomorphine and other dopaminomimetics, Villasimius, Cagliari, Italy, 1980 b."},{"key":"CR85","volume-title":"Bromocriptine: A Clinical and Pharmacological Review","author":"M. O. Thorner","year":"1980","unstructured":"Thorner, M. O., Fl\u00fcckiger, E., Calne, D. B.: Bromocriptine: A Clinical and Pharmacological Review. New York: Raven Press. 1980 c."},{"key":"CR86","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1210\/jcem-50-6-1026","volume":"50","author":"M. O. Thorner","year":"1980","unstructured":"Thorner, M. O., Schran, H. F., Evans, W. S., Rogol, A. D., Morris, J. L., Mac Leod, R. M.: A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: A study of serum prolactin and bromocriptine levels after acute and chronic administration of bromocriptine. J. Clin. Endocrinol. Metab.50, 1026\u20131033 (1980 d).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR87","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jcem-51-3-438","volume":"51","author":"M. O. Thorner","year":"1980","unstructured":"Thorner, M. O., Martin, W. H., Rogol, A. D., Morris, J. L., Perryman, R. L., Conway, B. P., Howards, S. S., Wolfman, M. G., Mac Leod, R. M.: Rapid regression of pituitary prolactinomas during bromocriptine treatment. J. Clin. Endocrinol. Metab.51, 438\u2013445 (1980 e).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR88","first-page":"281","volume":"12","author":"G. Tolis","year":"1975","unstructured":"Tolis, G., Pinter, E. J., Friesen, H. G.: The acute effect of 2-bromo-\u03b1-ergocryptine (CB 154) on anterior pituitary hormones and free fatty acids in man. Int. J. Clin. Pharmacol.12, 281\u2013283 (1975).","journal-title":"Int. J. Clin. Pharmacol."},{"key":"CR89","first-page":"291","volume-title":"Clinical Neuroendocrinology: A Pathophysiological Approach","author":"G. Tolis","year":"1979","unstructured":"Tolis, G., Franks, St.: Physiology and pathology of prolactin secretion. In: Clinical Neuroendocrinology: A Pathophysiological Approach (Tolis, G., ed.), pp. 291\u2013316. New York: Raven Press. 1979."},{"key":"CR90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1471-0528.1975.tb00718.x","volume":"82","author":"W. H. Utian","year":"1975","unstructured":"Utian, W. H., Begg, G., Uinik, A. I., Paul, M.: Effects of bromocriptine and dilorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study. Br. J. Obstet. Gynaecol.82, 755\u2013759 (1975).","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"CR91","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0140-6736(79)90120-X","volume":"2","author":"J. A. H. Wass","year":"1979","unstructured":"Wass, J. A. H., Thorner, M. O., Charlesworth, M., Moult, P. J. A., Dacie, J. E., Jones, A. E., Besser, G. M.: Reduction of pituitary tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy. Lancet2, 66\u201369 (1979).","journal-title":"Lancet"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jcem-51-4-724","volume":"51","author":"L. Whitfield","year":"1980","unstructured":"Whitfield, L., Sowers, J. R., Tuck, M. L., Golub, M. S.: Dopaminergic control of plasma catecholamines and aldosterone response to acute stimuli in normal man. J. Clin. Endocrinol. Metab.51, 724\u2013729 (1980).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"CR93","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/acta.0.0410321","volume":"41","author":"G. H. Zeilmaker","year":"1962","unstructured":"Zeilmaker, G. H., Carlsen, R. A.: Experimental studies on the effect of ergocornine methansulfonate on the luteotrophic function of the rat pituitary gland. Acta Endocrinol. (Kbh.)41, 321\u2013330 (1962).","journal-title":"Acta Endocrinol. (Kbh.)"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01664005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01664005\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01664005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T19:37:03Z","timestamp":1625945823000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01664005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,3]]},"references-count":93,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1981,3]]}},"alternative-id":["BF01664005"],"URL":"https:\/\/doi.org\/10.1007\/bf01664005","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,3]]}}}